Belgium· BE-AMP-SAM663806-00
Eltrombopag Viatris 50 mg
A eltrombopag product containing eltrombopag olamine, registered in Belgium by Viatris. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Eltrombopag is registered in 15 of 19 countries.
Countries holding a registration under ATC B02BX05 (eltrombopag), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Eltrombopag · ATC B02BX05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of eltrombopag costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eltrombopag · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$38.37
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Eltrombopag Olamine
- Manufacturer
- Viatris
- Country
- Belgium (BE)
- ATC code
- B02BX05
- ATC class
- Eltrombopag
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7748940
- be_apb5800339
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
175 interactions on record for eltrombopag.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eltrombopag · interactions on record
175 records
- 20 severe
- 153 moderate
- 2 minor
Most severe, free to view
- EluxadolineA07DA06severe
- BerotralstatB06AC06severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eltrombopag in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaELTROMBOPAG ABDIAbdi Farma GmbH, Heppenheim
- United StateseltrombopagNovadoz Pharmaceuticals LLC
- FinlandEltrombopag AccordAccord Healthcare S.L.U.
- IrelandEltrombopag Accord 50 mg film-coated tabletsAccord Healthcare S.L.U.
- FranceELTROMBOPAG BIOGARAN 50 mg, comprimé pelliculéBIOGARAN
- SwedenEltrombopag Teva GmbH 50 mg Filmdragerad tablettTEVA GmbH
- NorwayEltrombopag ZentivaZentiva k.s.
- GermanyEltrombopag ZentivaZentiva Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Eltrombopag Ratiopharm
- Bulgaria · Елтромбопаг Pht, Елтромбопаг Тева
- Czechia · Eltrombopag Teva
- Germany · Eltrombopag Ratiopharm, Eltrombopag Zentiva
- Denmark · Eltrombopag Zentiva
- Estonia · Eltrombopag Zentiva
- Spain · Eltrombopag Teva, Eltrombopag Zentiva
- France · Eltrombopag Arrow, Eltrombopag Sandoz
- United Kingdom (Northern Ireland) · Eltrombopag Tilllomed, Eltrombopag Tillomed
- Greece · Eltrombopag Ariti
- Croatia · Rulemya 25 Mg Tablete, Rulemya 50 Mg Tablete
- Italy · Eltrombopag Teva, Eltrombopag Zentiva
- Lithuania · Eltrombopag Teva, Eltrombopag Zentiva
- Luxembourg · Eltrombopag Ab
- Netherlands · Eltrombopag Aurobindo, Eltrombopag Teva
- Norway · Eltrombopag Teva, Eltrombopag Zentiva
- Poland · Eltrombopag Zentiva
- Portugal · Eltrombopag Generis, Eltrombopag Generis Phar
- Sweden · Eltrombopag Teva Gmbh, Eltrombopag Zentiva
- Slovakia · Eltrombopag Sandoz, Eltrombopag Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e41f8923-84fe-4c9b-98af-24f90f815205 GET /v1/drugs/e41f8923-84fe-4c9b-98af-24f90f815205?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Eltrombopag Viatris 50 mg",
"name_fr": "Eltrombopag Viatris 50 mg",
"name_nl": "Eltrombopag Viatris 50 mg",
"amp_code": "SAM663806-00",
"strengths": [
"50.0000",
"50.0000"
],
"pack_count": 6,
"substances": [
"Eltrombopag Olamine",
"Eltrombopag",
"Mannitol",
"Sodium Starch Glycolate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Eltrombopag",
"authorisation_numbers": [
"EU/1/24/1869/009",
"EU/1/24/1869/010",
"EU/1/24/1869/012",
"EU/1/24/1869/011",
"EU/1/24/1869/022",
"EU/1/24/1869/021"
]
}See everything about eltrombopag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.